Arcadia Biosciences, Inc. · NASDAQ:RKDA

Arcadia Biosciences — Q1 2021 Earnings Presentation

10 slides from Arcadia Biosciences's earnings presentation, May 17, 2021

  1. Slide 1: Q1 2021 Earnings Call

    ARCADIA BIOSCIENCES Q1 2021 Earnings Call May 17, 2021

  2. Slide 2: Forward Looking Statements

    FORWARD LOOKING STATEMENTS • “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This presentation contains forward-looking statements about the company and its products, including statements relating to projected revenue growth as a result of the asset acquisition; s

  3. Slide 3: Arcadia Growth Strategy

    ARCADIA BIOSCIENCES ARCADIA GROWTH STRATEGY Healthy people. 1 Create good-for-you foods & wellness products 2 sourced from our proprietary ingredient platforms 3 in wheat and hemp Position GoodWheat Leverage GoodHemp to become the global first mover advantage gold standard in the burgeoning seed & C

  4. Slide 4: The Transaction

    ARCADIA BIOSCIENCES THE TRANSACTION Portfolio of Brands • $6M annual recurring revenues; significant potential for growth & synergy revenues • 80 SKU’s, 17 product categories • Soul Spring #1 brand in CBD topicals in natural channel CBD Infused Botanical Therapy • National distribution; sold in more

  5. Slide 5: Synergies

    ARCADIA BIOSCIENCES SYNERGIES Arcadia Consumer Products Channel network 5,000+ Doors A. National distributors B. Direct to Independents Initially targeting Limited market 15% of installed base penetration to date Lief Consumer Products Saleable E-commerce platform Little on-line Target growth to pre

  6. Slide 6: CBD Market Overview

    ARCADIA BIOSCIENCES CBD MARKET OVERVIEW As the CBD market continues to ramp, there are opportunities for industry leaders to secure substantial margins throughout the value chain CBD category growth & drivers New public company Drink and other edibles poised to show strongest growth once entrants in

  7. Slide 7: Agrasys Assets

    ARCADIA BIOSCIENCES AGRASYS ASSETS • 10 Countries: ES, IT, NL, CH, DK, DE, FR, UK, BE, GR • 50 grain producers • 20 Milling/malting partners • 7 Retailers • Multiple product applications • Installed European base to grow the combined Goodwheat business • Projected breakeven in year 1 post- aquisitio

  8. Slide 8: GoodWheat Potential Product Categories

    GOODWHEAT POTENTIAL PRODUCT CATEGORIES ARCADIA BIOSCIENCES Pancake, Waffle Mixes Baking Mixes Snacks Pasta, Pizza Crust Cookies, Muffins, Quick Breads Crackers, Cereal Bars, Bagels  Lower calories  Lower calories  Higher fiber  Lower calories  Lower calories  Higher fiber  Higher protein  Hi

  9. Slide 9: Product Development and Launch

    PRODUCT DEVELOPMENT AND LAUNCH Product 1 Today formulation complete Brand developed Sales platform established 2021 Q2 Q3 Q4 Q1 2022 Product development May 2021 – Jul 2021 Brand and packaging May 2021 – Aug 2021 Sales and marketing strategy May 2021 – Oct 2021 Product Development Nov 2021 – Dec 202

  10. Slide 10: Key Financial Results

    KEY FINANCIAL RESULTS $ Favorable/ % Favorable/ $ in 000’s except per share data Q1 2021 Q1 2020 (Unfavorable) (Unfavorable) Total revenues $ 828 $ 309 $ 519 168% Cost of product revenues 856 132 (724) (548%) R&D expenses 1,159 2,244 1,085 48% Change in FV of contingent consideration (140) - 140 100

Arcadia Biosciences — Q1 2021 Earnings Presentation on 6ix